FDA approves first cell-based gene therapy for beta-thalassemia
The U.S. Food and Drug Administration has approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood ...
Aug 23, 2022
0
7
